To further confirm the high expression of RCN1 in AML, we assessed RCN1 mRNA levels by quantitative polymerase chain reaction (qPCR) in 43 BMMNC samples from AML patients and 45 G‐CSF‐mobilized PBSC samples from healthy donors. This evidence concerns the gene CSF3 and acute myeloid leukemia.